Recent ALC News
- Alcon Publishes Agenda for 2024 Annual General Meeting • Business Wire • 04/07/2024 09:59:00 PM
- Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India • Business Wire • 03/12/2024 08:30:00 AM
- Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone • Business Wire • 03/06/2024 02:55:00 PM
- Vivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implants • Business Wire • 03/06/2024 02:55:00 PM
- Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone • Business Wire • 03/06/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 11:44:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 10:56:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 06:12:20 PM
- Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023 • Business Wire • 02/27/2024 09:30:00 PM
- Algoma Central Corporation Reports Financial Results for Fiscal 2023 • Business Wire • 02/26/2024 12:00:00 PM
- Algoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024 • Business Wire • 02/12/2024 09:22:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/01/2024 06:04:56 PM
- Alcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytie • Business Wire • 02/01/2024 02:02:00 PM
- Algoma Central Corporation continues to grow product tanker business with the acquisition of two additional vessels • Business Wire • 01/18/2024 01:54:00 PM
- Alcon Shares Rise After Dry-Eye Care Drug Shows Promising Results • Dow Jones News • 01/10/2024 09:12:00 AM
- Alcon Reports Results for Dry-Eye-Treatment Trials • Dow Jones News • 01/09/2024 10:20:00 PM
- Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye • Business Wire • 01/09/2024 09:30:00 PM
- Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye • Business Wire • 01/09/2024 09:30:00 PM
- Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference • Business Wire • 12/27/2023 02:01:00 PM
- Alcon Down Over 5%, On Track for Largest Percent Decrease Since May 2022 -- Data Talk • Dow Jones News • 11/15/2023 04:08:00 PM
- Alcon's Swiss Shares Drop After Guidance Narrowed to Lower End of Range • Dow Jones News • 11/15/2023 11:11:00 AM
- Alcon Reports Third Quarter 2023 Results • Business Wire • 11/14/2023 09:30:00 PM
- Alcon Canada lance Clareon Vivity, sa plus récente avancée en matière de LIO pour la correction de la presbytie • Business Wire • 11/08/2023 02:03:00 PM
- Algoma Central Corporation Reports Financial Performance for the 2023 Third Quarter • Business Wire • 11/03/2023 07:00:00 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM